Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Completes Previously Announced Acquisition of Cardioxyl Pharmaceuticals, Inc.

[Business Wire] – Bristol-Myers Squibb Company today announced that it has completed the previously announced planned acquisition of Cardioxyl Pharmaceuticals, Inc. Read more on this. Bristol-Myers Squibb Company (BMY), valued at $115.78B, . . . → Read More: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Completes Previously Announced Acquisition of Cardioxyl Pharmaceuticals, Inc. Similar Articles: Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – FDA approves expanded use of Bristol-Myers’ skin cancer drug Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb’s Opdivo (nivolumab) Recipient of Prix Galien USA 2015 Award for Best Biotechnology Product Market Update: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Selects ZS to Support Global Commercial Analytics